1-6 of 6
lymphoid neoplasm, malignant
Close
Save search
Sort by
Journal Articles

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies

Free
Clinical Trials & Observations
Jennifer L. Crombie, Amy C. Sherman, Chi-An Cheng, Christine E. Ryan, Rebecca Zon, Michaël Desjardins, Peter Baker, Mikaela McDonough, Natalie Izaguirre, Bruce Bausk, Jonathan Krauss, Tal Gilboa, Yasmeen Senussi, David R. Walt, Matthew S. Davids, Jennifer R. Brown, Philippe Armand, Lindsey R. Baden, Nicolas Issa
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3062–3065.
https://doi.org/10.1182/bloodadvances.2021005328
Published: 2021
Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Free
Clinical Trials & Observations
Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1899–1902.
https://doi.org/10.1182/bloodadvances.2020003699
Published: 2021
Journal Articles

Treatment-free remission in FIP1L1-PDGFRA –positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation

Free
Clinical Trials & Observations
Georgia Metzgeroth, Juliana Schwaab, Nicole Naumann, Mohamad Jawhar, Torsten Haferlach, Alice Fabarius, Andreas Hochhaus, Wolf-Karsten Hofmann, Nicholas C. P. Cross, Andreas Reiter
Journal: Blood Advances
Blood Adv (2020) 4 (3): 440–443.
https://doi.org/10.1182/bloodadvances.2019001111
Published: 2020
Journal Articles

Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation–induced senescence

Free
Abigail M. Druck Shudofsky, Chou-Zen Giam
Journal: Blood Advances
Blood Adv (2019) 3 (4): 564–569.
https://doi.org/10.1182/bloodadvances.2018029322
Published: 2019
Journal Articles

Mature lymphoid malignancies: origin, stem cells, and chronicity

Free
Simon Husby, Kirsten Grønbæk
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2444–2455.
https://doi.org/10.1182/bloodadvances.2017008854
Published: 2017
Includes: Supplemental data
Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Free
Clinical Trials & Observations
Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1347–1357.
https://doi.org/10.1182/bloodadvances.2017007716
Published: 2017
Includes: Supplemental data